Yasmine Emara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yasmine Emara has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Matthias Finkbeiner
Chair of Sustainable Engineering, Technische Universität Berlin, Berlin, Germany
7 shared publications Annekatrin Lehmann
Chair of Sustainable Engineering, Technische Universität Berlin, Institute of Environmental Technology, Berlin, Germany
4 shared publications- Marc-William Siegert
Chair of Sustainable Engineering, Technische Universität Berlin, Institute of Environmental Technology, Berlin, Germany
4 shared publications - Annekatrin Lehmann
Technische Universität Berlin
2 shared publications Marc-William Siegert
Department of Environmental Technology, Technische Universität Berlin, Berlin, Germany
2 shared publications- Peter Fantke
Department for Evolutionary Ecology and Environmental Toxicology Goethe University Frankfurt am Main Germany
2 shared publications
Latest Publications
- Open Access
- 25 March 2022
- Published by Elsevier in Trends in Food Science & Technology
- Vol. 123, 310-321
Workflow for building interoperable food and nutrition security (FNS) data platforms
- 25 March 2022
- Published by Elsevier in Trends in Food Science & Technology
- Vol. 123, 310-321
Open AccessWorkflow for building interoperable food and nutrition security (FNS) data platforms
- 1 March 2021
- Published by Elsevier in Science of The Total Environment
- Vol. 762, 143874
Integrating endocrine-related health effects into comparative human toxicity characterization
- 1 March 2021
- Published by Elsevier in Science of The Total Environment
- Vol. 762, 143874
Integrating endocrine-related health effects into comparative human toxicity characterization
- Open Access
- 28 April 2020
- Published by Springer Nature in The International Journal of Life Cycle Assessment
- Vol. 25 (8) , 1633-1634
Correction to: Addressing the use and end-of-life phase of pharmaceutical products in life cycle assessment
- 28 April 2020
- Published by Springer Nature in The International Journal of Life Cycle Assessment
- Vol. 25 (8) , 1633-1634
Open AccessCorrection to: Addressing the use and end-of-life phase of pharmaceutical products in life cycle assessment
- 2 January 2020
- Published by Springer Nature in The International Journal of Life Cycle Assessment
- Vol. 25 (8) , 1436-1454
Addressing the use and end-of-life phase of pharmaceutical products in life cycle assessment
- 2 January 2020
- Published by Springer Nature in The International Journal of Life Cycle Assessment
- Vol. 25 (8) , 1436-1454
Addressing the use and end-of-life phase of pharmaceutical products in life cycle assessment
- 16 November 2018
- Published by Springer Nature in The International Journal of Life Cycle Assessment
- Vol. 24 (6) , 1040-1057
Harmonized rules for future LCAs on pharmaceutical products and processes
- 16 November 2018
- Published by Springer Nature in The International Journal of Life Cycle Assessment
- Vol. 24 (6) , 1040-1057
Harmonized rules for future LCAs on pharmaceutical products and processes
- 22 September 2018
- Published by Oxford University Press (OUP) in Integrated Environmental Assessment and Management
- Vol. 15 (1) , 6-18
Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): A review
Over the last few decades, worldwide detection of active pharmaceutical ingredients (APIs) in aquatic environments and the associated toxicological effects on wildlife and human health have become a matter of public and scientific debate. While life cycle assessment (LCA) and life cycle impact assessment (LCIA) models are increasingly used to assess the potential eco‐ and human‐toxicological impacts of chemical emissions, few studies have looked into the issue of modelling pharmaceutical emissions specifically and their toxicity‐related effects in an LCA‐context. This paper reviews the state‐of‐the‐art to inventory and characterize API emissions in LCA with the goal to identify relevant gaps and challenges. A search for 208 environmentally‐relevant APIs in two life cycle inventory (LCI) databases revealed a meagre representation of this group of chemicals. Similarly, the LCIA model USEtox® was found to include characterization factors (CFs) for less than 60 APIs. First approaches to model API emissions in LCA were identified on the basis of an examination of 40 LCA case studies in the pharmaceutical sector and in the field of wastewater treatment. Moreover, CFs for 79 additional APIs, expressing their ecotoxicity and/ or human toxicity potential were gathered from literature. An analysis of the variability of API‐CFs in different LCIA models showed a variation of about 2‐3 orders of magnitude. Based on the review results, three main gaps in the modelling and characterization of API emissions in an LCA‐context were identified: (1) incomplete modelling of API‐flows and API‐emissions along the life‐cycle of human pharmaceuticals, especially during their use and end‐of‐life phase, (2) limited API‐coverage in existing LCIA toxicity models and (3) missing pharma‐specific impact pathways (e.g. endocrine disruption and antibiotic resistance) in existing LCIA models. Recommendations to tackle these gaps are provided and priority action steps discussed. This article is protected by copyright. All rights reserved
- 22 September 2018
- Published by Oxford University Press (OUP) in Integrated Environmental Assessment and Management
- Vol. 15 (1) , 6-18
Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): A review
Over the last few decades, worldwide detection of active pharmaceutical ingredients (APIs) in aquatic environments and the associated toxicological effects on wildlife and human health have become a matter of public and scientific debate. While life cycle assessment (LCA) and life cycle impact assessment (LCIA) models are increasingly used to assess the potential eco‐ and human‐toxicological impacts of chemical emissions, few studies have looked into the issue of modelling pharmaceutical emissions specifically and their toxicity‐related effects in an LCA‐context. This paper reviews the state‐of‐the‐art to inventory and characterize API emissions in LCA with the goal to identify relevant gaps and challenges. A search for 208 environmentally‐relevant APIs in two life cycle inventory (LCI) databases revealed a meagre representation of this group of chemicals. Similarly, the LCIA model USEtox® was found to include characterization factors (CFs) for less than 60 APIs. First approaches to model API emissions in LCA were identified on the basis of an examination of 40 LCA case studies in the pharmaceutical sector and in the field of wastewater treatment. Moreover, CFs for 79 additional APIs, expressing their ecotoxicity and/ or human toxicity potential were gathered from literature. An analysis of the variability of API‐CFs in different LCIA models showed a variation of about 2‐3 orders of magnitude. Based on the review results, three main gaps in the modelling and characterization of API emissions in an LCA‐context were identified: (1) incomplete modelling of API‐flows and API‐emissions along the life‐cycle of human pharmaceuticals, especially during their use and end‐of‐life phase, (2) limited API‐coverage in existing LCIA toxicity models and (3) missing pharma‐specific impact pathways (e.g. endocrine disruption and antibiotic resistance) in existing LCIA models. Recommendations to tackle these gaps are provided and priority action steps discussed. This article is protected by copyright. All rights reserved
- Open Access
- 4 July 2018
- Published by Springer Nature
- p. 79-88
Life Cycle Management in the Pharmaceutical Industry Using an Applicable and Robust LCA-Based Environmental Sustainability Assessment Approach
- 4 July 2018
- Published by Springer Nature
- p. 79-88
Open AccessLife Cycle Management in the Pharmaceutical Industry Using an Applicable and Robust LCA-Based Environmental Sustainability Assessment Approach
- 1 February 2017
- Published by Elsevier in Journal of Cleaner Production
- Vol. 143, 1221-1232
Calculation of Fair wage potentials along products' life cycle – Introduction of a new midpoint impact category for social life cycle assessment
- 1 February 2017
- Published by Elsevier in Journal of Cleaner Production
- Vol. 143, 1221-1232
Calculation of Fair wage potentials along products' life cycle – Introduction of a new midpoint impact category for social life cycle assessment
- 24 April 2016
- Published by Springer Nature in The International Journal of Life Cycle Assessment
- Vol. 21 (10) , 1463-1472
Characterization model to assess ocean acidification within life cycle assessment
- 24 April 2016
- Published by Springer Nature in The International Journal of Life Cycle Assessment
- Vol. 21 (10) , 1463-1472
Characterization model to assess ocean acidification within life cycle assessment